Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peanut allergy.

Chyh-Woei Lee1, Albert L Sheffer

  • 1Harvard Medical School, Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Allergy and Asthma Proceedings
|September 17, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency.

BMC gastroenterology·2014
Same author

Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2013
Same author

Prospective, double-blind, placebo-controlled trials of ecallantide for acute attacks of hereditary angioedema.

Expert review of clinical immunology·2011
Same author

Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies.

The Journal of allergy and clinical immunology·2011
Same author

Ecallantide for the treatment of acute attacks in hereditary angioedema.

The New England journal of medicine·2010
Same author

The diagnosis and management of anaphylaxis practice parameter: 2010 update.

The Journal of allergy and clinical immunology·2010
Same journal

Key factors in the diagnosis of sesame allergy in children.

Allergy and asthma proceedings·2026
Same journal

Immunoglobulin E-mediated pumpkin seed allergy in children: Case series and narrative review with a structured literature search.

Allergy and asthma proceedings·2026
Same journal

Predictors of delayed treatment-free remission with omalizumab in chronic spontaneous urticaria.

Allergy and asthma proceedings·2026
Same journal

The digital front door: A national analysis of U.S. allergy and immunology fellowship program web sites.

Allergy and asthma proceedings·2026
Same journal

The impact of dietary patterns on the risk of asthma in children.

Allergy and asthma proceedings·2026
Same journal

The alpha-gal syndrome: Understanding the role of tick bites, and the delays in severe anaphylaxis.

Allergy and asthma proceedings·2026
See all related articles

Peanut allergies are a growing health concern, often causing severe reactions. Management includes avoidance, recognizing symptoms, and using epinephrine, with new therapies on the horizon.

Area of Science:

  • Allergy and Immunology
  • Clinical Medicine
  • Public Health

Background:

  • Peanut allergy is a significant and increasing health issue, particularly in Westernized countries.
  • It is a leading cause of severe food allergies and life-threatening anaphylactic reactions.
  • Most individuals diagnosed with peanut allergy experience lifelong sensitivity.

Purpose of the Study:

  • To review the current understanding of peanut allergy.
  • To cover clinical characteristics, pathogenesis, diagnosis, and management strategies.
  • To discuss emerging therapeutic approaches.

Main Methods:

  • Literature review of peanut allergy research.
  • Synthesis of information on clinical presentation and disease mechanisms.

Related Experiment Videos

  • Analysis of current and future treatment modalities.

    • Main Results:

    • Peanut allergy prevalence is rising, with most patients having persistent lifelong sensitivity.
    • Current management focuses on strict avoidance, early symptom recognition, and emergency epinephrine use.
    • Novel treatments like immunotherapy and anti-IgE therapy are being explored.

    Conclusions:

    • Peanut allergy requires comprehensive management strategies, including emergency preparedness.
    • Ongoing research into pathogenesis and treatment holds promise for improved patient outcomes.
    • Understanding clinical characteristics is crucial for effective diagnosis and care.